.png){kind=icon}
BackJournal Details
European Urology
IF25.2
Papers11983
Citations36975
Journal Papers 18305
Publication Date
.png){kind=icon}
Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.04.013.png)
European Urology.png)
.png)
Share.png)
Save
European UrologyIF25.2
PREAI
ShareSaveReply to Riccardo Lombardo’s Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveReply to Paolo Zaurito’s Letter to the Editor re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveRe: Pierre-Etienne Gabriel, Alec Zhu, Paolo Gontero, Morgan Rouprêt, Evanguelos Xylinas, John P Sfakianos. BCG-unresponsive NMIBC: An Obsolete Definition in a Multimodal and Evolving Therapeutic Landscape. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.028European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveReply to Pierre-Etienne Gabriel and Evanguelos Xylinas’s Letter to the Editor re: Ding Ding, Lei Qian, Di Jin, et al. Aptamer-based Positron Emission Tomography Imaging Allows Specific Detection of Residual Bladder Cancer: A First-in-Human Study. Eur Urol. 2026;89:93–5European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveRe: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion-targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveRe: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.007European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveRe: Agne Krilaviciute, Nikolaus Becker, Sigrid V. Carlsson, et al. Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-aged Men – Data from the PROBASE Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.06.016European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveRe: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.007European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSaveReply to Renate Pichler and José Daniel Subiela’s Letter to the Editor re: Can Aydogdu, Laura Bukavina, Liang Cheng, et al. Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.030European UrologyShareSave
European UrologyIF25.2
PREAI
ShareSave